Kiora Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Lincoln Park Capital Fund, LLC(9.99%),Lincoln Park Capital, LLC(9.99%)等
Kiora Pharmaceuticals | D:發行公告
Kiora Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%)等
Kiora Pharmaceuticals | SC 13G:超過5%持股股東披露文件
Kiora Pharmaceuticals | SC 13G:超過5%持股股東披露文件-AIGH Capital Management, LLC(9.9%),Orin H(9.9%)
Kiora Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Mitchell P. Kopin(1.5%),Daniel B. Asher(1.5%)等
Kiora Pharmaceuticals | 4:持股變動聲明-高管 Tosca Melissa
Kiora Pharmaceuticals | 4:持股變動聲明-高管 Daniels Eric Joseph
Kiora Pharmaceuticals | 4:持股變動聲明-高管 Strem Brian M.
Kiora Pharmaceuticals | 4:持股變動聲明-董事 TYLE PRAVEEN
Kiora Pharmaceuticals | 4:持股變動聲明-董事 Shapiro Aron
Kiora Pharmaceuticals | 4:持股變動聲明-董事 Stengone Carmine N.
Kiora Pharmaceuticals | 4:持股變動聲明-董事 Hollander David
Kiora Pharmaceuticals | 4:持股變動聲明-董事 Gayron Kenneth L
Kiora Pharmaceuticals | 4:持股變動聲明-董事 Parsons Erin
Kiora Pharmaceuticals | 3:首次持股聲明-董事 Stengone Carmine N.
Kiora Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%)等
Kiora Pharmaceuticals | 4:持股變動聲明-董事 Parsons Erin
Kiora Pharmaceuticals | 4:持股變動聲明-高管 Tosca Melissa
Kiora Pharmaceuticals | 4:持股變動聲明-高管 Strem Brian M.
暫無數據